MYO3A and breast carcinoma: The expression of TAM-derived MIP-1β or CCL4 chemokine relates to poor survival in breast cancer patients, potentiating breast cancer cell invasion and metastasis through increased myosin IIIA (MYO3A) gene expression [58].